ATI RN
Cardiovascular System Exam
1. What is a condition where the heart muscle becomes thickened without an obvious cause, leading to a reduction in the heart's ability to pump blood?
- A. Hypertrophic cardiomyopathy
- B. Dilated cardiomyopathy
- C. Restrictive cardiomyopathy
- D. Myocarditis
Correct answer: A
Rationale: Hypertrophic cardiomyopathy is the correct answer. It is a condition characterized by the abnormal thickening of the heart muscle without an obvious cause, which impairs the heart's ability to effectively pump blood. Dilated cardiomyopathy (choice B) involves the enlargement and weakening of the heart chambers, not thickening. Restrictive cardiomyopathy (choice C) refers to the stiffening of the heart muscle, limiting its ability to fill properly. Myocarditis (choice D) is inflammation of the heart muscle usually caused by a viral infection, not thickening.
2. What is a condition where a blood clot forms in a deep vein, usually in the legs, and can lead to serious complications if it travels to the lungs?
- A. Deep vein thrombosis (DVT)
- B. Pulmonary embolism
- C. Varicose veins
- D. Raynaud's disease
Correct answer: A
Rationale: The correct answer is A, Deep vein thrombosis (DVT). Deep vein thrombosis occurs when a blood clot forms in a deep vein, usually in the legs. If the clot dislodges and travels to the lungs, it can lead to a serious condition called a pulmonary embolism. Choice B, pulmonary embolism, is incorrect as it is the consequence of a DVT clot traveling to the lungs, not the initial condition. Choices C and D, varicose veins, and Raynaud's disease, respectively, are unrelated conditions to the formation of blood clots in deep veins.
3. Which of the following is a rare but serious condition where the pulmonary arteries become narrowed, increasing the blood pressure in the lungs?
- A. Pulmonary hypertension
- B. Pulmonary embolism
- C. Pulmonary fibrosis
- D. Aortic stenosis
Correct answer: A
Rationale: The correct answer is A, Pulmonary hypertension. Pulmonary hypertension is a rare but serious condition characterized by high blood pressure in the arteries of the lungs, which can lead to heart failure. Pulmonary embolism (choice B) involves a blockage in one of the pulmonary arteries in the lungs. Pulmonary fibrosis (choice C) is a lung disease that causes lung tissue scarring. Aortic stenosis (choice D) is a condition where the aortic valve narrows, affecting blood flow from the heart.
4. The client is on a beta blocker for hypertension. What should the nurse monitor for?
- A. Bradycardia
- B. Tachycardia
- C. Hypertension
- D. Respiratory distress
Correct answer: A
Rationale: Corrected Rationale: When a client is on a beta blocker for hypertension, the nurse should monitor for bradycardia. Beta blockers are known to decrease heart rate, which can lead to bradycardia. Tachycardia (choice B) is unlikely as beta blockers have the opposite effect. Hypertension (choice C) is the condition being treated, not a side effect of beta blockers. Respiratory distress (choice D) is not a common effect of beta blockers and is not typically monitored in clients taking beta blockers.
5. What is a surgical procedure to remove one of the lobes of the lungs, often performed to treat lung cancer?
- A. Lobectomy
- B. Pneumonectomy
- C. Thoracotomy
- D. Tracheostomy
Correct answer: A
Rationale: A lobectomy is the correct answer. This surgical procedure involves removing one of the lobes of the lungs, commonly done to treat lung cancer or other serious lung ailments. Choice B, pneumonectomy, involves the complete removal of a lung, not just a lobe. Choice C, thoracotomy, is a surgical incision into the chest wall and is not specific to removing a lung lobe. Choice D, tracheostomy, is the creation of an opening in the windpipe to assist with breathing and is unrelated to lung lobe removal.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access